These are exciting times, with fresh news about research developments appearing every week.
Find out about the latest research news below and also visit our Breaking News in Research page.
The results from the MDUK-funded research project gives insight into the drugs, ezutromidRead more
The ENMC is an international organisation that supports research for neuromuscular conditions and strives to facilitate communication among scientists and clinicians.
Muscular Dystrophy UK is investing £1.2 million into 9 new research projects this year, bringing our total research portfolio to over £10m.
A new study has explored parents' perspectives on clinical trials and what influences their decision to enrol their child.
Dr Tedesco from UCL worked in collaboration with Dr Popplewell and Prof Dickson from RHUL to develop an artificial chromosome containing the entire dystrophin gene.
We would like to inform you of a research study for adults with progressive muscle weakness caused by muscular dystrophy or inclusion body myositis (IBM).
A phase 3 trial has found that it could be beneficial for people with Duchenne and Becker muscular dystrophy to be treated with ACE inhibitors before heart weakness is detected.
We are inviting you to join ACTMuS, a new study sponsored by King’s College Hospital and funded by the National Institute of Health Research and Muscular Dystrophy UK.
Prof Dame Kay Davies and Richard Pye from Summit Therapeutics answered your questions on utrophin up-regulation.
We are pleased to announce that we are investing nearly £440,000 into three new Duchenne muscular dystrophy research projects that came out of our grant round.
We are delighted to announce that we are investing approximately £1.7 million into 10 new research projects that came out of our grant rounds.